Cargando…

Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA

BACKGROUND: Osteoarthritis (OA) is a major cause of limb dysfunction, and distraction arthroplasty which generates intermittent hydrostatic pressure (IHP) is an effective approach for OA treatment. However, the result was not always satisfactory and the reasons remained unresolved. Because aging is...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Hanhao, Chen, Ran, Gui, Chang, Tao, Tianqi, Ge, Yingbin, Zhao, Xilian, Qin, Ran, Yao, Wangxiang, Gu, Song, Jiang, Yiqiu, Gui, Jianchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249424/
https://www.ncbi.nlm.nih.gov/pubmed/32450920
http://dx.doi.org/10.1186/s13287-020-01708-5
_version_ 1783538590694768640
author Dai, Hanhao
Chen, Ran
Gui, Chang
Tao, Tianqi
Ge, Yingbin
Zhao, Xilian
Qin, Ran
Yao, Wangxiang
Gu, Song
Jiang, Yiqiu
Gui, Jianchao
author_facet Dai, Hanhao
Chen, Ran
Gui, Chang
Tao, Tianqi
Ge, Yingbin
Zhao, Xilian
Qin, Ran
Yao, Wangxiang
Gu, Song
Jiang, Yiqiu
Gui, Jianchao
author_sort Dai, Hanhao
collection PubMed
description BACKGROUND: Osteoarthritis (OA) is a major cause of limb dysfunction, and distraction arthroplasty which generates intermittent hydrostatic pressure (IHP) is an effective approach for OA treatment. However, the result was not always satisfactory and the reasons remained unresolved. Because aging is recognized as an important risk factor for OA and chondrogenic progenitor cells (CPCs) could acquire senescent phenotype, we made a hypothesis that CPCs senescence could have harmful effect on chondrogenesis and the outcome of distraction arthroplasty could be improved by eliminating senescent CPCs pharmacologically. METHODS: The role of senescent CPCs on distraction arthroplasty was first determined by comparing the cartilage samples from the failure and non-failure patients. Next, the biological behaviors of senescent CPCs were observed in the in vitro cell culture and IHP model. Finally, the beneficial effect of senescent CPCs clearance by senolytic dasatinib and quercetin (DQ) on cartilage regeneration was observed in the in vitro and in vivo IHP model. RESULTS: Larger quantities of senescent CPCs along with increased IL-1 β secretion were demonstrated in the failure patients of distraction arthroplasty. Senescent CPCs revealed impaired proliferation and chondrogenic capability and also had increased IL-1 β synthesis, typical of senescence-associated secretory phenotype (SASP). CPCs senescence and SASP formation were mutually dependent in vitro. Greater amounts of senescent CPCs were negatively correlated with IHP-induced chondrogenesis. In contrast, chondrogenesis could be significantly improved by DQ pretreatment which selectively induced senescent CPCs into apoptosis in the in vitro and in vivo IHP model. Mechanistically, senescent CPCs elimination could decrease SASP formation and therefore promote the proliferation and chondrogenic regeneration capacity of the surrounding survived CPCs under IHP stimulation. CONCLUSIONS: Eliminating senescent CPCs by senolytics could decrease SASP formation and improve the result of joint distraction arthroplasty effectively. Our study provided a novel CPCs senescence-based therapeutic target for improving the outcome of OA treatment.
format Online
Article
Text
id pubmed-7249424
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72494242020-06-04 Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA Dai, Hanhao Chen, Ran Gui, Chang Tao, Tianqi Ge, Yingbin Zhao, Xilian Qin, Ran Yao, Wangxiang Gu, Song Jiang, Yiqiu Gui, Jianchao Stem Cell Res Ther Research BACKGROUND: Osteoarthritis (OA) is a major cause of limb dysfunction, and distraction arthroplasty which generates intermittent hydrostatic pressure (IHP) is an effective approach for OA treatment. However, the result was not always satisfactory and the reasons remained unresolved. Because aging is recognized as an important risk factor for OA and chondrogenic progenitor cells (CPCs) could acquire senescent phenotype, we made a hypothesis that CPCs senescence could have harmful effect on chondrogenesis and the outcome of distraction arthroplasty could be improved by eliminating senescent CPCs pharmacologically. METHODS: The role of senescent CPCs on distraction arthroplasty was first determined by comparing the cartilage samples from the failure and non-failure patients. Next, the biological behaviors of senescent CPCs were observed in the in vitro cell culture and IHP model. Finally, the beneficial effect of senescent CPCs clearance by senolytic dasatinib and quercetin (DQ) on cartilage regeneration was observed in the in vitro and in vivo IHP model. RESULTS: Larger quantities of senescent CPCs along with increased IL-1 β secretion were demonstrated in the failure patients of distraction arthroplasty. Senescent CPCs revealed impaired proliferation and chondrogenic capability and also had increased IL-1 β synthesis, typical of senescence-associated secretory phenotype (SASP). CPCs senescence and SASP formation were mutually dependent in vitro. Greater amounts of senescent CPCs were negatively correlated with IHP-induced chondrogenesis. In contrast, chondrogenesis could be significantly improved by DQ pretreatment which selectively induced senescent CPCs into apoptosis in the in vitro and in vivo IHP model. Mechanistically, senescent CPCs elimination could decrease SASP formation and therefore promote the proliferation and chondrogenic regeneration capacity of the surrounding survived CPCs under IHP stimulation. CONCLUSIONS: Eliminating senescent CPCs by senolytics could decrease SASP formation and improve the result of joint distraction arthroplasty effectively. Our study provided a novel CPCs senescence-based therapeutic target for improving the outcome of OA treatment. BioMed Central 2020-05-25 /pmc/articles/PMC7249424/ /pubmed/32450920 http://dx.doi.org/10.1186/s13287-020-01708-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dai, Hanhao
Chen, Ran
Gui, Chang
Tao, Tianqi
Ge, Yingbin
Zhao, Xilian
Qin, Ran
Yao, Wangxiang
Gu, Song
Jiang, Yiqiu
Gui, Jianchao
Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA
title Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA
title_full Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA
title_fullStr Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA
title_full_unstemmed Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA
title_short Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA
title_sort eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of oa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249424/
https://www.ncbi.nlm.nih.gov/pubmed/32450920
http://dx.doi.org/10.1186/s13287-020-01708-5
work_keys_str_mv AT daihanhao eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT chenran eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT guichang eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT taotianqi eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT geyingbin eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT zhaoxilian eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT qinran eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT yaowangxiang eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT gusong eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT jiangyiqiu eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa
AT guijianchao eliminatingsenescentchondrogenicprogenitorcellsenhanceschondrogenesisunderintermittenthydrostaticpressureforthetreatmentofoa